Saarland University Medical Center and Saarland University Faculty of Medicine
Innere Medizin V - Pneumologie, Allergologie, Beatmungs- und Umweltmedizin
Leitung: Prof. Dr. med. Dr. rer. nat. Robert Bals
You are here: >> Startseite >> Klinische Zentren und Einrichtungen >> Departments and Institutes >> Medizinische Kliniken >> Innere Medizin V >> Research >> Research Team Prof. Dr. Dr. Robert Bals >> Publications

Research Team Prof. Dr. Dr. Robert Bals

Publications

All publications

 

Selected papers and books

 

  1. Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest. 1998;102(5):874-80. IF = 14.2
  2. Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A. 1998;95(16):9541-6. IF = 10.9
  3. Bals R, Welsch U, Bosch TCG. Isolation and molecular characterization of serous and mucous gland cells of the porcine airways. Am J Respir Cell Mol Biol. 1998;18(4):548-53. IF = 4.2
  4. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol. 2001;31(10):3026-37. IF = 5.0
  5. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest. 2003;111(11):1665-72. IF = 14.1
  6. Lepper PM, Ott S, Nuesch E, von Eynatten M, Schumann C, Pletz MW, Mealing NM, Welte T, Bauer TT, Suttorp N, Juni P, Bals R, Rohde G, German Community Acquired Pneumonia Competence N. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ. 2012;344:e3397. IF = 16.4
  7. Li D, Beisswenger C, Herr C, Schmid RM, Gallo RL, Han G, Zakharkina T, Bals R. Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth. Oncogene. 2014;33(21):2709-16. IF = 8.4
  8. Karch A, Vogelmeier C, Welte T, Bals R, Kauczor H-U, Biederer J, Heinrich J, Schulz H, Gläser S, Holle R, Watz H, Korn S, Adaskina N, Biertz F, Vogel C, Vestbo J, Wouters EFM, Rabe KF, Söhler S, Koch A, Jörres RA. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. Respiratory Medicine. 2016;114:27-37. IF = 3.8
  9. Trudzinski FC, Kaestner F, Schafers HJ, Fahndrich S, Seiler F, Bohmer P, Linn O, Kaiser R, Haake H, Langer F, Bals R, Wilkens H, Lepper PM. Outcome of Patients with Interstitial Lung Disease Treated with Extracorporeal Membrane Oxygenation for Acute Respiratory Failure. Am J Respir Crit Care Med. 2016;193(5):527-33. IF = 13.2
  10. Bernhard N, Lepper PM, Vogelmeier C, Seibert M, Wagenpfeil S, Bals R, Fahndrich S. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ. Respir Med. 2017;130:1-8. IF = 3.5
  11. Buhl R, Bals R, Baur X, Berdel D, Criee CP, Gappa M, Gillissen A, Greulich T, Haidl P, Hamelmann E, Kardos P, Kenn K, Klimek L, Korn S, Lommatzsch M, Magnussen H, Nicolai T, Nowak D, Pfaar O, Rabe KF, Riedler J, Ritz T, Schultz K, Schuster A, Spindler T, Taube C, Taube K, Vogelmeier C, von Leupold A, Wantke F, Weise S, Wildhaber J, Worth H, Zacharasiewicz A. [Guideline for the Diagnosis and Treatment of Asthma - Guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology]. Pneumologie. 2017;71(12):e2. IF = 0.07
  12. Houben-Wilke S, Jorres RA, Bals R, Franssen FM, Glaser S, Holle R, Karch A, Koch A, Magnussen H, Obst A, Schulz H, Spruit MA, Wacker ME, Welte T, Wouters EF, Vogelmeier C, Watz H. Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study. Am J Respir Crit Care Med. 2017;195(2):189-97. IF = 13.2
  13. Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Branscheidt M, Eschmann R, Bals R. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:31. IF = 4.8
  14. Hiemstra PS, McCray PB, Jr., Bals R. The innate immune function of airway epithelial cells in inflammatory lung disease. Eur Respir J. 2015;45(4):1150-62. IF = 4.1
  15. Hiemstra PS, Bals R. Effects of E-cigarette Use on Human Lung Tissue: On Harm Reduction and Causing Harm. Am J Respir Crit Care Med. 2018. IF = 4.8
  16. Schönhofer B und R. Bals. COPD und Asthma bronchiale in der Intensivmedizin, in: Evidence based medicine in Anästhesie und der Intensivmedizin. Springer Verlag, Herausgeber: R. Kuhlen und R. Roissant, 2007: 253-269.
  17. Bals, R., Köhnlein, T. Alpha-1-Antitrypsin-Mangel. Thieme. 2010.
  18. Lorenz, J. and Bals., R. Checkliste XXL Pneumologie, Thieme, 2016